CRISPR-mediated gene editing to rescue haploinsufficient obesity syndrome.
作者信息
Wang Zhifeng, Yang Liu, Qu Shen, Zhang Chao
机构信息
Translational Medical Center for Stem Cell Therapy and Institute for Regenerative Medicine, Shanghai East Hospital, Shanghai Key Laboratory of Signaling and Disease Research, School of Life Sciences and Technology, Tongji University, Shanghai, 200092, China.
Research & Development Department, Sinoneural Cell and Gene Engineering Holdings Co., Ltd., Shanghai, China.
出版信息
Protein Cell. 2019 Oct;10(10):705-708. doi: 10.1007/s13238-019-0635-y.
Abstract
摘要
相似文献
1
CRISPR-mediated gene editing to rescue haploinsufficient obesity syndrome.利用CRISPR介导的基因编辑来挽救单倍剂量不足肥胖综合征。
Protein Cell. 2019 Oct;10(10):705-708. doi: 10.1007/s13238-019-0635-y.
2
[Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].成簇规律间隔短回文重复序列（CRISPR）/CRISPR相关蛋白9系统在干细胞研究中的应用进展
Zhonghua Shao Shang Za Zhi. 2018 Apr 20;34(4):253-256. doi: 10.3760/cma.j.issn.1009-2587.2018.04.013.
3
[Application of clustered regularly interspaced short palindromic repeats- associated protein 9 gene editing technology for treatment of HBV infection].[成簇规律间隔短回文重复序列相关蛋白9基因编辑技术在治疗乙型肝炎病毒感染中的应用]
Zhonghua Gan Zang Bing Za Zhi. 2018 Nov 20;26(11):860-864. doi: 10.3760/cma.j.issn.1007-3418.2018.11.012.
4
CRISPR/Cas System: Recent Advances and Future Prospects for Genome Editing.CRISPR/Cas 系统：基因组编辑的最新进展和未来前景。
Trends Plant Sci. 2019 Dec;24(12):1102-1125. doi: 10.1016/j.tplants.2019.09.006. Epub 2019 Nov 11.
5
Genome editing: CRISPR-Cas becoming more human.基因组编辑：CRISPR-Cas技术愈发贴近人类应用。
Nat Rev Mol Cell Biol. 2017 Oct;18(10):591. doi: 10.1038/nrm.2017.84. Epub 2017 Aug 16.
6
[CRISPR-Cas9 mediated genome editing in Caenorhabditis elegans].[CRISPR-Cas9介导的秀丽隐杆线虫基因组编辑]
Sheng Wu Gong Cheng Xue Bao. 2017 Oct 25;33(10):1693-1699. doi: 10.13345/j.cjb.170177.
7
Genome editing: The efficient tool CRISPR-Cpf1.基因组编辑：高效工具CRISPR-Cpf1
Nat Plants. 2017 Mar 3;3:17028. doi: 10.1038/nplants.2017.28.
8
In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges.用于治疗性基因编辑的CRISPR/Cas9体内递送：进展与挑战
Bioconjug Chem. 2017 Apr 19;28(4):880-884. doi: 10.1021/acs.bioconjchem.7b00057. Epub 2017 Mar 17.
9
Expanding the Scope of CRISPR/Cpf1-Mediated Genome Editing in Rice.扩大CRISPR/Cpf1介导的水稻基因组编辑范围
Mol Plant. 2018 Jul 2;11(7):995-998. doi: 10.1016/j.molp.2018.03.009. Epub 2018 Mar 20.
10
CRISPR-Cas in its prime.处于鼎盛时期的CRISPR-Cas
Nat Rev Mol Cell Biol. 2019 Dec;20(12):718-719. doi: 10.1038/s41580-019-0194-3.
引用本文的文献
1
Syndromic and Monogenic Obesity: New Opportunities Due to Genetic-Based Pharmacological Treatment.综合征性和单基因肥胖：基于基因的药物治疗带来的新机遇。
Children (Basel). 2024 Jan 25;11(2):153. doi: 10.3390/children11020153.
2
Patient derived model of -associated encephalopathy identifies defects in neurodevelopment and highlights potential therapies.患者来源的与……相关的脑病模型识别出神经发育缺陷并突出了潜在治疗方法。 （你提供的原文中“-associated”这里应该有具体疾病名称缺失，我是按照完整理解来翻译的。）
bioRxiv. 2024 Jan 27:2024.01.25.577254. doi: 10.1101/2024.01.25.577254.
3
Genome Editing and Obesity.基因组编辑与肥胖症
Adv Exp Med Biol. 2023;1396:179-190. doi: 10.1007/978-981-19-5642-3_12.
本文引用的文献
1
Tailoring the CRISPR system to transactivate coagulation gene promoters in normal and mutated contexts.定制 CRISPR 系统以在正常和突变背景中转激活凝血基因启动子。
Biochim Biophys Acta Gene Regul Mech. 2019 Jun;1862(6):619-624. doi: 10.1016/j.bbagrm.2019.04.002. Epub 2019 Apr 18.
2
A Neuron-Optimized CRISPR/dCas9 Activation System for Robust and Specific Gene Regulation.神经元优化的 CRISPR/dCas9 激活系统，用于稳健且特异性的基因调控。
eNeuro. 2019 Mar 7;6(1). doi: 10.1523/ENEURO.0495-18.2019. eCollection 2019 Jan-Feb.
3
Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogramming.异常增强子低甲基化通过全局转录重编程促进肝癌发生。
Nat Commun. 2019 Jan 18;10(1):335. doi: 10.1038/s41467-018-08245-z.
4
CRISPR-mediated activation of a promoter or enhancer rescues obesity caused by haploinsufficiency.CRISPR 介导的启动子或增强子激活可挽救单倍不足引起的肥胖。
Science. 2019 Jan 18;363(6424). doi: 10.1126/science.aau0629. Epub 2018 Dec 13.
5
In utero CRISPR-mediated therapeutic editing of metabolic genes.子宫内 CRISPR 介导的代谢基因治疗性编辑。
Nat Med. 2018 Oct;24(10):1513-1518. doi: 10.1038/s41591-018-0184-6. Epub 2018 Oct 8.
6
In vivo CRISPR editing with no detectable genome-wide off-target mutations.体内 CRISPR 编辑，未检测到全基因组脱靶突变。
Nature. 2018 Sep;561(7723):416-419. doi: 10.1038/s41586-018-0500-9. Epub 2018 Sep 12.
7
In dogs, CRISPR fixes a muscular dystrophy.在狗身上，CRISPR技术修复了一种肌肉萎缩症。
Science. 2018 Aug 31;361(6405):835. doi: 10.1126/science.361.6405.835.
8
Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy.基因编辑恢复了杜氏肌营养不良犬模型中的肌营养不良蛋白表达。
Science. 2018 Oct 5;362(6410):86-91. doi: 10.1126/science.aau1549. Epub 2018 Aug 30.
9
Meganuclease targeting of PCSK9 in macaque liver leads to stable reduction in serum cholesterol.靶向 PC SK9 的 Meganuclease 在猕猴肝脏中可稳定降低血清胆固醇。
Nat Biotechnol. 2018 Sep;36(8):717-725. doi: 10.1038/nbt.4182. Epub 2018 Jul 9.
10
Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.基因治疗与 CRISPR/Cas9 渐趋成熟，有望攻克 HIV。
AIDS Rev. 2017 Oct-Dec;19(3):167-172.
Zotero 插件